CB

Christine Bee

BS Bristol-Myers Squibb: 9 patents #582 of 3,969Top 15%
FT Five Prime Therapeutics: 1 patents #73 of 117Top 65%
📍 San Francisco, CA: #4,897 of 26,999 inventorsTop 20%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #536,988 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12312403 Antibodies against TIM3 and uses thereof Xiao Min Schebye, Mark J. Selby, Michelle Minhua HAN, Andy X. Deng, Anan Chuntharapai +10 more 2025-05-27
12129297 Antibodies against TIM3 and uses thereof Xiao Min Schebye, Mark J. Selby, Michelle Minhua HAN, Andy X. Deng, Anan Chuntharapai +10 more 2024-10-29
12077584 Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2024-09-03
11981734 Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2024-05-14
11591392 Antibodies against TIM3 and uses thereof Xiao Min Schebye, Mark J. Selby, Michelle Minhua HAN, Andy X. Deng, Anan Chuntharapai +10 more 2023-02-28
11401328 Antibodies binding to ILT4 Xiao Min Schebye, Diana Yuhui Chen, Andrew Rankin, Xiaodi Deng, Joseph Toth +9 more 2022-08-02
11274150 Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies Natalie Bezman, Alan J. Korman, Shrikant Deshpande, Amy D. Jhatakia, Richard Y. Huang +5 more 2022-03-15
10533052 Antibodies against TIM3 and uses thereof Xiao Min Schebye, Mark J. Selby, Michelle Minhua HAN, Andy X. Deng, Anan Chuntharapai +10 more 2020-01-14
10077306 Antibodies against TIM3 and uses thereof Xiao Min Schebye, Mark J. Selby, Michelle Minhua HAN, Andy X. Deng, Anan Chuntharapai +10 more 2018-09-18